The streptolydigin biosynthetic gene cluster from Streptomyces lydicus NRRL 2433 contains three putative regulatory genes, slgR1, slgR2 and slgY, encoding proteins belonging to TetR and LuxR transcriptional regulator families and ATP/GTP-binding proteins of DNA and RNA helicase superfamily I, respectively. Inactivation of slgR1 or slgR2 resulted in the abolition of streptolydigin production, suggesting that these proteins are pathway-specific positive regulators. In the case of the slgR1 mutant, low amounts of streptolydigin C were produced instead of streptolydigin. RT-PCR transcription analysis of streptolydigin biosynthesis genes revealed a hierarchical regulation process. SlgY was found to control the expression of the regulator slgR2. SlgR2 regulates the expression of structural genes involved in the formation of the streptolydigin bicyclic ketal moiety, incorporation and processing of 3-methylaspartate, and the regulator slgR1. On the other hand, SlgR1 controls the expression of slgE1-E2, involved in the conversion of glutamate to 3-methylaspartate, and putative glycoside hydrolases slgC1 and slgC2. Ectopic expression of slgR1, slgR2 and slgY regulatory genes in S. lydicus led to considerable increases in streptolydigin yields, 18-, 11-and 8.5-fold, respectively. Ectopic expression of slgY in an slgR1 mutant led to a 14-fold increase of streptolydigin C yields, while no effect was observed to result from expression of slgR2.
INTRODUCTION
Micro-organisms of the genus Streptomyces are Grampositive bacteria belonging to the phylum Actinobacteria (Ventura et al., 2007) , and have a complex life cycle of morphological differentiation which begins with a spore that germinates to give a substrate mycelium and later an aerial mycelium, followed by a sporulation stage (Chater, 1998) . These micro-organisms produce an extraordinary diversity of antibiotics and other biologically active secondary metabolites of medical and industrial significance (Bérdy, 2005) . Regulation of secondary metabolism in Streptomyces is a complex process operating at different levels (Bibb, 2005; Huang et al., 2005; Chater & Chandra, 2008; Liras et al., 2008) . Expression of antibiotic biosynthesis gene clusters is controlled by different families of regulatory proteins. Complex regulatory cascades link environmental and physiological signals with pleiotropic and pathway-specific regulatory proteins which control the expression of individual antibiotic gene clusters. Pathwayspecific regulatory genes are usually clustered with genes for the biosynthesis of the antibiotic and genes involved in secretion and resistance. They can either activate or repress the expression of gene cluster elements. Clusters may contain different numbers of pathway-specific positive regulatory genes, ranging from one in the actinorhodin pathway (Fernández-Moreno et al., 1991) to three in the daunorubicin pathway (Otten et al., 2000; Jiang & Hutchinson, 2006) . In addition, some clusters contain activators and repressors simultaneously, such as the tylosin cluster, which contains two of each (Cundliffe, 2008) , or the a-lipomycin cluster, which contains four positive regulatory genes and one repressor (Horbal et al., 2010) . Knowledge of the mechanisms of regulation at the molecular level is of great interest and would potentially allow an increase in the yields of secondary metabolites in the producer strains by overexpression of pathway-specific positive regulators or by inactivation of pathway repressors (Olano et al., 2008; Chen et al., 2010) .
Streptolydigin, a polyketide-nonribosomal peptide compound member of the tetramic acids family (Schobert & Schlenk, 2008) , is a potent inhibitor of bacterial RNA polymerase (Temiakov et al., 2005; Tuske et al., 2005; Sánchez-Hidalgo et al., 2010) . In addition, it inhibits the eukaryotic terminal deoxynucleotidyltransferase (DiCioccio & Srivastava, 1976; DiCioccio et al., 1980) . Studies on the streptolydigin gene cluster have led us to unravel its biosynthesis pathway ( Fig. 1 ) and to generate several novel streptolydigin analogues by combinatorial biosynthesis (Olano et al., 2009; Horna et al., 2011; Gó mez et al., 2011 Gó mez et al., , 2012a Gó mez et al., , 2012b . Two putative regulatory genes, slgR1 and slgR2, whose deduced products share significant similarity with different families of bacterial regulatory proteins involved in transcriptional activation, have been identified in the streptolydigin gene cluster (Olano et al., 2009) . In addition, the deduced product of slgY, which shows similarity to ATP/GTP-binding proteins, could be involved in regulatory processes. The aim of the present study was to provide evidence for the functional role of these proteins in the streptolydigin producer Streptomyces lydicus NRRL 2433. The results presented here show that SlgR1, SlgR2 and SlgY are pathway-specific transcriptional activators of streptolydigin biosynthetic genes and key factors in the control of streptolydigin biosynthesis. These findings are further supported by the expression of each regulatory gene in S. lydicus, leading to significant improvements in streptolydigin yields.
METHODS
Strains and culture conditions. The bacterial strains used in this work were S. lydicus NRRL 2433, streptolydigin producer, Escherichia coli DH10B (Invitrogen, Fisher Scientific) and ET12567 (pUB307). Tryptone soya broth (TSB) was used as growth medium for S. lydicus and mutants. Medium MA was used for sporulation and R5A as production medium (Fernández et al., 1998) . Intergeneric conjugation of Streptomyces mycelium was performed following standard procedures (Kieser et al., 2000) . The E. coli media were those described in the literature (Sambrook et al., 1989) . When plasmidcontaining clones were grown, the medium was supplemented with the appropriate antibiotics: 100 mg ampicillin ml
21
, 20 mg tobramycin ml 21 , 25 mg apramycin ml 21 , 50 mg thiostrepton ml 21 , 50 mg hygromycin ml 21 , 10 mg tetracycline ml 21 , 25 mg chloramphenicol ml 21 or 50 mg nalidixic acid ml 21 .
DNA manipulation and plasmids. DNA manipulations were performed according to standard procedures for E. coli (Sambrook et al., 1989) and Streptomyces (Kieser et al., 2000) . Platinum Pfx DNA polymerase (Invitrogen) and 2.5 % (v/v) DMSO were used for all PCR amplifications. PCR conditions used were 97 uC, 5 min; 30 cycles of 95 uC, 30 s, 55 uC, 45 s and 68 uC, 1 min; and a final extension cycle at 68 uC, 10 min. All the PCR products were cloned into pCR-BLUNT (Invitrogen) and then sequenced. Other plasmids used in this work were pEFBAoriT for gene replacement and pEM4T (Menéndez et al., 2006) for gene expression. pLHyg (Olano et al., 2004) was used as donor of the hygromycin-resistance gene hyg.
Construction of plasmids for gene inactivation and complementation of mutants. Plasmids pDslgR1Hyg, pDslgR2Hyg, pDslgYHyg and pDslg5-28 were generated for inactivation of slgR1, slgR2, slgY and deletion of the slgN2 to slgC1 region, respectively. The three constructs derived from plasmid pEFBAoriT and PCR fragments, of approximately 1 kb each, were cloned into SpeI-NsiI and BamHI-EcoRV sites flanking the apramycin-resistance gene aac3(IV). For inactivating slgR1, PCR fragments were amplified from cosmid Slg6E5 (Olano et al., 2009 ) using oligoprimers CRIST1A/ CRIST1B and CRIST2A/CRIST2B (Table 1) . These PCR products contained the slgY gene and 10 bp from the 39 end of slgR1, and 3 bp from the 59 end of the slgR1 and slgT genes, respectively. PCR fragments using oligoprimers CRISL1A/CRISL1B and CRISL2A/ CRISL2B (Table 1) were amplified from cosmid Slg4A8 (Olano et al., 2009) and included the slgN2 gene and 6 bp from the 39 end of slgR2, and 8 bp from the 59 end of the slgR2 and orf2 genes, respectively. Cosmid SlgA48 was also used for the amplification of PCR products using oligoprimers CRISB1A/CRISB1B and CRISB2A/CRISB2B (Table 1) , which contained the slgR1 gene and 11 bp of the 39 end of slgY, and 6 bp of the 59 end of the slgY and slgE2 genes, respectively. After subcloning these fragments in plasmid pEFBAoriT, the resultant constructs pDslgR1, pDslgR2 and pDslgY were digested with XbaI, and the hyg gene from pLHyg was 
subcloned as a SpeI-NheI fragment to obtain the final plasmids used for generation of S. lydicus mutant strains SLMR1, SLMR2 and SLMY, respectively. To delete the DNA region containing slgN2 to slgC1, PCR fragments were amplified from cosmids Slg6E5 and Slg4A8 (Olano et al., 2009 ) using oligoprimers CCL1/CCL2 and CCL3/CCL4 (Table 1) . These PCR products, containing the entire slgR2 and slgB genes, respectively, were subcloned into pEFBAoriT, leading to pDslg5-28, used to obtain S. lydicus mutant strain SLM5A28.
For complementation of S. lydicus mutants SLMR1, SLMR2 and SLMY, plasmids pEM4TslgR1, pEM4TslgR2 and pEM4TslgY were constructed by subcloning in plasmid pEM4T the respective genes amplified by PCR as BamHI-EcoRI fragments. In these constructs, genes slgR1, slgR2 and slgY are under the control of the ermE* promoter. The slgR1 gene was amplified by PCR from cosmid Slg6E5 using oligoprimers CRIS36 and CRIS37 (Table 1) , while slgR2 and slgY were amplified from cosmid Slg4A8 using oligoprimers CRIS33/ CCL2 and CRIS42/CRIS43 (Table 1) , respectively. In the case of the slgR2 PCR product, the EcoRI site came from plasmid pCR-BLUNT used for initial cloning and verification by sequencing of the amplified fragment.
For expression of slgX in S. lydicus, the gene was amplified by PCR from cosmid Slg4A8 using oligoprimers CRIS38 and CRIS39 (Table 1) . The resultant fragment was digested with BglII and EcoRI, and subcloned into pEM4T, leading to pEM4TslgX. For expression of slgT in SLM5A28, the gene was amplified by PCR from cosmid Slg4A8 using oligoprimers CRIS50F and CRIS51R (Table 1 ). The resultant fragment was digested with BglII and EcoRI, and subcloned into pEM4T, leading to pEM4TslgT.
Generation of S. lydicus mutant strains. Constructs pDslgR1Hyg, pDslgR2Hyg and pDslgYHyg were introduced into wild-type S. lydicus, and construct pDslg5-28 was introduced into S. lydicus strain SLM7H13 (Olano et al., 2009 ) by intergeneric conjugation from E. coli ET12567 (pUB307). In all cases an apramycin-and hygromycinresistant mutant, obtained by a single-crossover event, was grown in the absence of antibiotics and then screened for the loss of hygromycin resistance, retaining apramycin resistance because of a double recombination event. The deletion events in mutants SLMR1, SLMR2 and SLM5A28 were verified by Southern hybridization and PCR amplification using oligoprimers CRIST1A/CRIST2B, CRISL1A/ CRISL2B and CCL1/CCL4 (Table 1) , respectively. Plasmids pEM4T, pEM4TslgR1, pEM4TslgR2, pEM4TslgY, pEM4TslgX and pEM4TslgT were introduced into the S. lydicus wild-type strain or mutants SLMR1, SLMR2 and SLM5A28 by intergeneric conjugation, and transconjugants were selected for resistance to thiostrepton.
Ultra high performance liquid chromatography (UPLC) and liquid chromatography (LC)-MS analyses. Streptolydigin production in S. lydicus wild-type or mutant strains grown on R5A medium was analysed by UPLC (Acquity UPLC equipment with a BEH C18 Waters column of 2.16100 mm) and LC-MS (Alliance chromatographic system coupled to a ZQ4000 mass spectrometer and a Symmetry C18 Waters column of 2.16150 mm) (Waters Cromatografía) using procedures previously described (Olano et al., 2009) . Cultures in liquid medium were performed using square deepwell plates consisting of 24 wells of 3 ml culture volume each (Siebenberg et al., 2010) . Precultures of S. lydicus were prepared in 250 ml baffled Erlenmeyer flasks containing 50 ml TSB medium. Cultivation was carried out at 30 uC and 250 r.p.m. for 2 days. Then, square deepwell plates containing R5A medium were inoculated at a 1 : 80 ratio and cultivated at 30 uC and 300 r.p.m. for 7 days.
Isolation of total RNA and gene expression analysis. Mycelium from R5A liquid cultures of S. lydicus NRRL 2433 and mutants SLMR1, SLMR2, SLM5A28 and SLM5A28Y was obtained at 72 h following the procedure described before . Transcript detection analysis was carried out by using the SuperScript One-Step RT-PCR with Platinum Taq DNA polymerase (Invitrogen) and 100 ng total RNA as template. DMSO (5 %, v/v, final concentration) was added to all reactions along with RNAguard RNase inhibitor (32.2 U per reaction) (Amersham Pharmacia Biotech). Conditions were those described previously (Gó mez et al., 2011), but using specific amplification temperatures depending of each set of primers. Primers listed in Table 1 were used to generate PCR products of different lengths, from 461 to 800 bp. Negative controls for each pair of primers were carried out with Platinum Taq DNA polymerase (Invitrogen) in the absence of reverse transcriptase to confirm that amplified products were not due to the presence of contaminating chromosomal DNA in RNA preparations. Oligonucleotides HRDB-GB1-F and HRDB-GB2-R for hrdB (Rodríguez et al., 2008; Gó mez et al., 2011) , which encodes the constitutively expressed housekeeping sigma factor, were used as an internal control to normalize RNA samples. The RT-PCR analysis was carried out at least three times for each pair of primers, and the RT-PCR products were separated in agarose gels and visualized by ethidium bromide staining. The identity of the PCR products was verified by direct sequencing with one of the amplification primers. (Hirano et al., 2008) . The involvement of SlgR1 in regulation of streptolydigin biosynthesis was assessed by deletion of slgR1 from S. lydicus (Fig. 3a) , thus generating mutant SLMR1. Analysis of the products accumulated by this mutant showed the production of a compound with UV spectrum characteristic of streptolydigin and a retention time of 6.5 min (Fig. 3b) . This compound, with masses of 587 and 473 m/z [M+H] + , ions corresponding to the unfragmented compound and the aglycon fragment (generated during MS analysis), respectively, co-migrates with the streptolydigin analogue streptolydigin C previously characterized from S. lydicus mutant SLMZ and also produced by mutant SLME1E2 (Gó mez et al., 2011). Streptolydigin C (Fig. 1) contains a tetramic acid side chain based on glutamate instead of 3-methylaspartate. This result suggests that SlgR1 might control the expression of genes involved in the conversion of glutamate into 3-methylaspartate (slgE1-E2) or in the tailoring modification of 3-methylaspartate (slgZ) Horna et al., 2011 (Walker et al., 1982) . In addition, these proteins contain a C-terminal LuxR-type HTH DNA-binding motif, absent however in LipReg4 (Fig. 2b) . Inactivation of slgR2 by gene replacement led to mutant SLMR2, which under UPLC analysis of culture extracts showed the complete abolition of streptolydigin production (Fig. 3b ).
The slgY product shows similarity to ATP/GTP-binding proteins belonging to superfamily I of DNA and RNA helicases (COG3973), including TamG (74 % identity) and TrdG (75 % identity) from tirandamycin gene clusters in Streptomyces sp. 307-9 (5) and Streptomyces sp. SCSIO1666 (Mo et al., 2011) . Proteins of this family are involved in DNA lydicus. S. lydicus carrying pEM4T (Ct) was used as a control. Cultures were performed on R5A solid medium and streptolydigin production was determined by HPLC analysis. Experiments were run in triplicate.
replication, repair, recombination and transcription (Tuteja & Tuteja, 2004) . SlgY, like other members of this family, contains an ATP-binding domain composed of Walker A and B motifs (Fig. 2c) . Initially, SlgY was ascribed as a protein with unknown function in the streptolydigin pathway (Olano et al., 2009) . Repeated attempts to inactivate slgY either by gene replacement or by gene disruption were unsuccessful, using both intergeneric conjugation and protoplast transformation of S. lydicus. The stability of the constructs used in these experiments was exhaustively verified, confirming that they were correct. Considering that SlgY could have a role in regulating not only streptolydigin biosynthesis but also self-resistance, a different approach was used. We generated a streptolydigin nonproducing mutant, SLM5A28, by deleting the DNA region going from slgN2 to slgC1 (both genes included) (Fig. 3a) . In this mutant, lacking most of the streptolydigin structural genes and the regulator gene slgR1, putative transporter gene slgT and slgY, we tested the capability to grow in the presence of streptolydigin. The minimal streptolydigin concentration that completely inhibited growth (MIC) was .200 mg ml 21 for S. lydicus wild-type and 100 mg ml 21 for mutant SLM5A28, thus suggesting that SlgT and/or SlgY might be involved in streptolydigin resistance. Expression of slgT under the control of the constitutive ermE* promoter (plasmid pEM4TslgT) in SLM5A28 restored streptolydigin resistance to wild-type levels, while no effect was observed by expression of slgY (plasmid pEM4TslgY). These results confirm the involvement of SlgT in streptolydigin resistance together with the previously identified streptolydiginresistance determinant rpoB, encoding the b-subunit of RNA polymerase (Sánchez-Hidalgo et al., 2010) .
Complementation of mutant strains and expression of slgR1, slgR2 and slgY in S. lydicus Mutant strains SLMR1 and SLMR2 were complemented using the corresponding gene under the control of the ermE* promoter using the constructs pEM4TslgR1 and pEM4TslgR2, respectively. In both cases, streptolydigin biosynthesis was restored by the corresponding regulatory gene (data not shown). In addition, cross-complementation experiments were performed to study the hierarchy of each regulator by expressing each regulatory gene in either mutant strain. In this case, complementation using pEM4TslgY (carrying slgY) was also attempted. However, none of the mutants recovered production of streptolydigin by expression of a different regulatory gene. Only in the case of SLMR1 was a 14-fold increase in the biosynthesis of streptolydigin C observed by expressing slgY (data not shown). This result suggests that SlgY is probably involved in the regulation of common genes required for the production of streptolydigin and streptolydigin C, i.e. polyketide synthase (PKS), nonribosomal peptide synthase (NRPS) and L-rhodinose biosynthesis encoding genes.
The three putative regulatory genes were also overexpressed in the S. lydicus wild-type strain to evaluate their effect on the biosynthesis of streptolydigin. The expression of each regulatory gene led to a considerable increase of streptolydigin yields. The best improvement, 18-fold, was obtained with slgR1, followed by 11-and 8.5-fold increases achieved by expressing slgR2 and slgY, respectively (Fig. 3c) . These results confirm the positive effect of these regulatory genes in streptolydigin biosynthesis.
Transcriptional analysis of the streptolydigin gene cluster
The effect of each regulatory gene in the expression of the different streptolydigin biosynthesis genes was monitored in the S. lydicus wild-type strain and in mutant strains SLMR1 and SLMR2. In addition to slgR1, slgR2 and slgY, 16 genes of the cluster were selected for this study: slgA1 slgN1, slgN2, slgL, slgO1, slgO2, slgE2, slgE3, slgZ and slgM, required to generate streptolydigin aglycon; slgS7 and slgG, involved in the biosynthesis and attachment of L-rhodinose; slgT, involved in streptolydigin transport and resistance; slgC1 and slgC2, involved in glucose supply for streptolydigin biosynthesis; and finally slgX, of unknown function (Fig.  4a) . In addition, the expression of slgR2 and slgA1 was also monitored in mutant strains SLM5A28 and SLM5A28Y (SLM5A28 carrying pEM4TslgY). Total RNA was isolated at 72 h, when streptolydigin was being produced , from cultures of the S. lydicus wild-type strain and mutants SLMR1, SLMR2, SLM5A28 and SLM5A28Y.
All genes were found to be transcribed in S. lydicus wild-type strain at 72 h, when streptolydigin was actively produced (Fig. 4b) . However, expression of four genes of the cluster, slgE2, slgC1, slgC2 and slgX, was undetectable in the slgR1 deletion mutant SLMR1. The remaining streptolydigin biosynthesis genes, as expected due to the production of streptolydigin C (including regulators slgR2 and slgY) were expressed in SLMR1 (Fig. 4b) . The lack of slgE2 expression is in agreement with the production of streptolydigin C by SLMR1. SlgE2 is the large subunit of the glutamate mutase involved in the conversion of glutamate into 3-methylaspartate during streptolydigin biosynthesis (Gó mez et al., 2011). Since SlgR1 controls the expression of slgX, which encodes a protein containing a terpene synthase signature and showing similarity to ent-copalyl diphosphate synthases, and inactivation of this gene has no effect on streptolydigin biosynthesis (Olano et al., 2009) , slgX was overexpressed in S. lydicus to evaluate a possible positive effect on streptolydigin yields, as has been previously reported for slgC1 and slgC2 (Gó mez et al., 2012b) . Consequently, plasmid pEM4TslgX was introduced by conjugation into S. lydicus and the production of streptolydigin monitored by UPLC. The expression of slgX under the control of the ermE* promoter led to a twofold increase in the production of streptolydigin (Fig. 3c) , thus confirming that it must have a role, even if it remains unknown, during the biosynthesis of the tetramic acid.
Expression of eight genes, slgR1, slgO2, sglL, slgE2, slgZ, slgC1, slgC2 and slgX, was not detected in slgR2-deleted mutant SLMR2 (Fig. 4b) . Since SlgR1 has been shown previously to control the expression of slgE2, slgC1, slgC2 and slgX, SlgR2 must be responsible for the expression of regulator slgR1 and at least the structural genes slgO2 and slgL. SlgO2 and SlgL have been previously reported to be strictly required for streptolydigin biosynthesis (Gó mez et al., 2012a) .
Transcription of two genes, slgR2 and slgA1, was evaluated in mutant SLM5A28 (Fig. 4d) , and only slgA1 was detected, implying that the expression of streptolydigin PKS genes is not controlled by the pathway-specific regulators identified in the gene cluster (Fig. 4e) . To determine whether transcription of slgR2 depends on the presence of SlgY, this was also monitored in strain SLM5A28Y. In this case, slgR2 was detected, thus confirming the regulatory effect of SlgY (Fig. 4e) .
DISCUSSION
Isolation of the streptolydigin biosynthesis gene cluster from S. lydicus NRRL 2433 has helped unravel the biosynthetic pathway for streptolydigin. According to these studies the biosynthesis of the streptolydigin main core involves the participation of a type I PKS (SlgA1, SlgA2 and SlgA3), an NRPS system (SlgN1, SlgN2 and SlgL) and a cytochrome P450 (SlgO2) required for streptolydigin bicyclic ketal formation (Olano et al., 2009; Gó mez et al., 2012a) . Supply of the streptolydigin amino acid precursor and its modification involve the participation of ferredoxin-dependent glutamate synthase SlgE3, glutamate mutase SlgE2 and SlgE1, 3-methylasparagine synthetase SlgZ and methyltransferase SlgM Horna et al., 2011) . The final steps of streptolydigin biosynthesis involve tailoring modifications consisting of epoxidation (SlgO1) and biosynthesis and attachment of L-rhodinose (SlgS1-S7 and SlgG) (Olano et al., 2009; Gó mez et al., 2012a) . Furthermore, putative glycoside hydrolases encoded by slgC1 and slgC2 have been shown to enhance streptolydigin yields by their expression in S. lydicus (Gó mez et al., 2012b) .
The streptolydigin biosynthesis gene cluster contains three putative regulatory genes, slgR1, slgR2 and slgY. Inactivation of slgR1 abolished streptolydigin production and led to the accumulation of streptolydigin C. Interestingly, inactivation of the slgR1 counterpart in the tirandamycin cluster, trdK, leads to an increase of tirandamycin yields, which implies that TrdK acts as a repressor (Mo et al., 2011) . Clearly, regulatory proteins that belong to the same family and regulate the production of analogous compounds can exert different regulatory activities. SlgR1, a TetR-family transcriptional regulator, activates the expression of at least four genes of the streptolydigin cluster, as has been shown by RT-PCR expression analysis in the SLMR1 mutant. The proteins encoded by these genes are involved in the supply and modification of an amino acid precursor (SlgE2), encode for putative glycoside hydrolases (SlgC1 and SlgC2) or, in the case of SlgX, do not have an assigned function, although its expression enhances streptolydigin yields. A further proof that SlgR1 regulates slgE2 is the fact that mutant SLMR1 (slgR1-minus mutant) accumulates the same compound, streptolydigin C, as mutant SLME1E2 lacking the glutamate mutase system (Gó mez et al., 2011).
Inactivation of slgR2 completely abrogates biosynthesis of streptolydigin. This effect was also observed in the biosynthesis of the tetramic acids a-lipomycin and tirandamycin upon inactivation of slgR2 homologues lipReg4 and trdH in Streptomyces aureofaciens Tü117 (Horbal et al., 2010) and Streptomyces sp. SCSIO1666 (Mo et al., 2011) , respectively. The SlgR2 LAL regulator activates not only essential streptolydigin biosynthesis genes (slgO2 and slgL) but also the regulatory gene slgR1. On the other hand, SlgY is required to activate the expression of SlgR2 and perhaps also other genes in the cluster involved in the biosynthesis of streptolydigin C. Consistent with this, the expression of slgY in the slgR1-deleted mutant SLMR1 led to enhanced streptolydigin C production. This effect could imply that SlgY controls the expression not only of the regulatory gene slgR2 but also of structural genes required for the production of streptolydigin C such as slgE3, slgM, slgN1, slgN2 and slgS3 to slgS7 that apparently are not regulated by SlgR2 or SlgR1. According to the pathway-specific regulatory roles of SlgR1, SlgR2 and SlgY, the ectopic expression of each streptolydigin regulatory gene in S. lydicus has a considerable effect on improving streptolydigin yields. In particular, the expression of slgR1 led to an 18-fold increase in streptolydigin yields, suggesting that production of the amino acid precursor is one of the limiting steps during streptolydigin biosynthesis. The effect of slgR1 on streptolydigin production can be applied to improve the poor yields of streptolydigin analogues generated in previous studies (Olano et al., 2009; Gó mez et al., 2011; Horna et al., 2011) .
In addition to a pathway-specific regulation of streptolydigin biosynthesis, a pleiotropic regulation of the cluster cannot be discarded but rather might be anticipated. In this sense, there are four TTA codons scattered along the streptolydigin gene cluster: two in slgR2 and one in the slgG and slgA1 coding regions. The presence of these TTA codons implies an upper level of control during streptolydigin production by a gene homologous to the pleiotropic regulatory gene bldA encoding a Leu-tRNA (Chater & Chandra, 2008) . This pleiotropic regulation would switch on streptolydigin biosynthesis by allowing the production of SlgR2, required for activating the expression of slgR1 and other structural genes. On the other hand, the PKS gene slgA1 is expressed in the absence of streptolydigin pathway-specific regulators; thus, synthesis of SlgA1 might be controlled at least by the expression of a bldA-like gene. The same might apply for the expression of the glycosyltransferase gene slgG.
Based on these results, streptolydigin biosynthesis is tightly regulated by three pathway-specific positive regulators acting in a hierarchical process that involves, in addition, other pleiotropic regulatory elements. Consequently, we propose the following model for the regulation of streptolydigin biosynthesis in S. lydicus, consisting of the sequential activation of all regulatory and structural genes (Fig. 5 ). In this model, the presence of a Leu-tRNA encoded by a bldAlike gene is required to activate streptolydigin biosynthesis, since there are TTA codons present in slgR2, slgA1 and slgG. On the other hand, the pathway-specific regulatory protein SlgY switches on transcription of the regulator slgR2 and probably other genes in the cluster. Expression of slgY might be controlled by pleiotropic regulators, an issue that remains to be clarified. The LAL regulator SlgR2 determines the expression of the regulator slgR1 and at least that of structural genes slgZ, slgL and slgO2, which are strictly required for the biosynthesis of streptolydigin and streptolydigin C. Biosynthesis of streptolydigin instead of streptolydigin C requires the expression of genes involved in formation and modification of the amino acid precursor. For this process, SlgR1 is essential, since it controls at least the expression of slgE2, which encodes the E-chain of the glutamate mutase. In addition, SlgR1 controls the expression of slgC1, slgC2 and slgX, genes not strictly required for the biosynthesis of streptolydigin but which might participate in the process, since their independent overexpression in S. lydicus enhances streptolydigin biosynthesis.
